Savara
SVRA
#6534
Rank
S$1.10 B
Marketcap
S$5.40
Share price
-7.05%
Change (1 day)
-5.00%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -S$0.18 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.16 Billion a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.18 Billion17.98%
2025 -S$0.16 Billion23.94%
2024 -S$0.13 Billion75.29%
2023 -S$70.02 Million43.38%
2022 -S$48.84 Million-11.31%
2021 -S$55.07 Million-13.3%
2020 -S$63.51 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$87.97 Million105.54%
2017 -S$42.8 Million34.11%
2016 -S$31.92 Million-37.43%
2015 -S$51 Million38.81%
2014 -S$36.75 Million33.62%
2013 -S$27.5 Million38.49%
2012 -S$19.86 Million24.59%
2011 -S$15.94 Million-36.5%
2010 -S$25.1 Million-3.14%
2009 -S$25.91 Million-23.28%
2008 -S$33.78 Million8.52%
2007 -S$31.12 Million-34.14%
2006 -S$47.26 Million184.43%
2005 -S$16.62 Million90.75%
2004 -S$8.71 Million190.35%
2003 -S$3 Million11.64%
2002 -S$2.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.11 Billion-42.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.25 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA